COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada

20/06/2018 - 01:35

VICTORIA, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) today applauds the Canadian government’s historic passing of Bill C-45 (Cannabis Act) to [...]

The Ensign Group Acquires Office Building in Orange County, California

20/06/2018 - 01:03

MISSION VIEJO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and [...]

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia and Hypercholesterolemia in Japan

20/06/2018 - 01:00

LA JOLLA, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

Trillium Therapeutics Announces “At-The-Market” Issuance Program and Filing of Prospectus Supplement

20/06/2018 - 00:30

TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSX:TRIL) (“Trillium” or the “Company”), a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]

Vigil Health Solutions Reports Record Sales Bookings for Fiscal 2018

19/06/2018 - 23:53

VICTORIA, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-V:VGL) announces the results of operations for the fiscal year and the fourth quarter, ending March 31, 2018. [...]

RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso

19/06/2018 - 22:14

Glen Rock, N.J, June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. announces the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of Directors (“Board”) of [...]

CORRECTING and REPLACING -- Pascal Biosciences Engages CFN Media to Build New Investor Audience -- CFN Media

19/06/2018 - 22:12

SEATTLE, June 19, 2018 (GLOBE NEWSWIRE) -- In a release issued today under the same headline by CFN Media, please be advised that the compensation that Pascal has made for CFN Media has been added to the About CFN Media [...]

Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology

19/06/2018 - 22:05

Data Previously Presented in 2017 at the 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) DUBLIN, Ireland, June 19, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a [...]

Verrica Pharmaceuticals Inc. Announces Closing of Initial Public Offering

19/06/2018 - 22:05

WEST CHESTER, Pa., June 19, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

19/06/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - June 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018

19/06/2018 - 22:01

CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq:BIIB) today announced it will host a live webcast providing an overview of its efforts targeting acute ischemic stroke on Thursday, June 28, 2018. The [...]

AB Science reports positive IDMC recommendation based on an interim analysis of the masitinib phase 3 study in prostate cancer

19/06/2018 - 19:23

Paris, June 19, 2018, 7pm AB Science reports positive IDMC recommendation based on an interim analysis of the masitinib phase 3 study in first-line treatment of castrate-resistant prostate cancer AB Science SA (NYSE [...]

AB Science annonce la recommandation positive de l'IDMC suite à l'analyse intérimaire de l'étude de phase 3 du masitinib dans le traitement du cancer de la prostate

19/06/2018 - 19:23

Paris, 19 juin, 2018, 19h AB Science annonce la recommandation positive de l'IDMC suite à l'analyse intérimaire de l'étude de phase 3 du masitinib dans le traitement en première ligne du cancer de la prostate [...]

CrownBio Enters Partnership with Pierre Fabre to Accelerate Discovery and Development of Immuno-Oncology Agents

19/06/2018 - 14:00

SAN DIEGO, June 19, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic [...]

Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina

19/06/2018 - 14:00

BASKING RIDGE, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology platforms targeting [...]

VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference

19/06/2018 - 14:00

CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]

Nexstim Plc resolved on a new stock option plan 2018, amendments of the stock options 2016 and cancellation of stock options 2013 held by the company

19/06/2018 - 16:36

Company Announcement, Helsinki, 19 June 2018 at 5:35 PM Nexstim Plc resolved on a new stock option plan 2018, amendments of the stock options 2016 and cancellation of stock options 2013 held by the company Stock options [...]

Nexstim Plc resolved on drawing the loan granted by Kreos Capital V Limited and the issuance of related warrants

19/06/2018 - 16:31

Company announcement, Helsinki, 19 June 2018 at 5:30 PM Nexstim Plc resolved on drawing the loan granted by Kreos Capital V Limited and the issuance of related warrants Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or [...]

Spine Injury Solutions Announces Quad Video HALO in an upcoming national PBS TV segment

19/06/2018 - 16:08

Dr. William F. Donovan, Chairman CEO of Spine Injury Solutions and subsidiary, Quad Video HALO™, Inc. (QVH) has recently been invited to have its QVH featured on “Innovations in Medicine,” a syndicated show under the [...]